Checkpoint Capital L.P. reported 6 holdings worth US$390M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Checkpoint Capital L.P. reported 6 holdings worth US$390M as of Jun 30, 2026. Largest: Rhythm Pharmaceuticals, Inc., Argenx Se and Revolution Medicines, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 6
- Value as reported
- US$390M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. | 1.19M | US$132M | 33.8% |
| Argenx Se | 131K | US$122M | 31.3% |
| Revolution Medicines, Inc. | 410K | US$76.9M | 19.7% |
| Cytokinetics, Incorporated | 475K | US$40.5M | 10.4% |
| Disc Medicine, Inc. | 240K | US$17.6M | 4.5% |
| Trevi Therapeutics, Inc. | 75,000 | US$1.4M | 0.36% |
| Crinetics Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Septerna, Inc. | 0 | US$0 | 0.00% |